Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.250
-0.100 (-4.26%)
At close: May 14, 2025, 4:00 PM
2.330
+0.080 (3.56%)
After-hours: May 14, 2025, 5:32 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $84.76 million as of May 14, 2025. Its market cap has decreased by -75.84% in one year.
Market Cap
84.76M
Enterprise Value
-28.49M
1-Year Change
-75.84%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $84.76M, a decrease of -82.64%. That is a compound annual growth rate of -36.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 88.53M | -67.80% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.76B |
| Johnson & Johnson | 357.16B |
| AbbVie | 332.08B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 282.47B |
| Abbott Laboratories | 224.53B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |